Notification of the sex and needle-sharing partners of individuals with human immunodeficiency virus in rural South Carolina: 30-month experience

Sexually Transmitted Diseases

Volumn 18, Issue 4, 1991, Pages 217-222

  Wykoff, Randolph F ^a   Jones, Jeffrey L ^a   Longshore, Sharon T ^a   Hollis, Shirley L ^a   Quiller, Clarence B ^a   Dowda, Harold ^a   Gamble, William B ^a  

^a Environmental Control ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD; CONTACT EXAMINATION; DRUG ABUSE; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; RISK FACTOR; RURAL POPULATION; SEXUALITY; SUBSTANCE ABUSE; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CONTACT TRACING; FEMALE; FOLLOW-UP STUDIES; HEALTH BEHAVIOR; HIV ANTIBODIES; HIV INFECTIONS; HOMOSEXUALITY; HUMAN; MALE; MIDDLE AGE; NEEDLE SHARING; RISK FACTORS; RURAL POPULATION; SEXUAL PARTNERS; SOUTH CAROLINA; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0026236756     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/00007435-199110000-00004     Document Type: Article

References (42)

1. Cates W, Holmes KK. Sexually transmitted diseases. In: Last JM, ed. Maxcy-Rosenau Public Health and Preventive Medicine, ed 12. Norwalk, CT: Appleton-Century-Crofts, 1986; 257-281.
2. Wykoff RF, Heath CW, Hollis SL, et al. Contact tracing to identify human immunodeficiency virus infection in a rural community. JAMA 1988; 259:3563-3566.
3. Centers for Disease Control. Partner notification for preventing human immunodeficiency virus (HIV) infection-Colorado, Idaho, South Carolina, Virginia. MMWR 1988; 37:393-396, 401-402.
4. Vernon TM, Hoffman RE. Contact tracing to control the spread of HIV. JAMA 1988; 260:3274.
5. Adler MW, Johnson AM. Contact tracing for HIV infection. Br Med J 1988; 296:1420-1421.
6. Echenberg DE. A new strategy to prevent the spread of AIDS among heterosexuals. JAMA 1985; 254:2129-2130.
7. Wykoff RF. Preventing the spread of AIDS. JAMA 1986; 1706-1707.
8. Gostin L, Curran WJ. AIDS screening, confidentiality and the duty to warn. Am J Publ Health 1987; 77:361-365.
9. Kegeles SM, Catania JA, Coates TJ. Intention to communicate positive HIV antibody status to sex partners. JAMA 1988; 259:216-217.
10. Potterat JJ, Spencer NE, Woodhouse DE, Muth JB. Partner notification in the control of human immunodeficiency virus infection. Am J Publ Health 1989; 79:874-876.
11. Zonana H. Warning third parties at risk of AIDS: APA’s policy is a reasonable approach. Hospital and Community Psychiatry 1989; 40:162-164.
12. Judson FN. What do we really know about AIDS control? Am J Publ Health 1989; 79:878-883.
13. Wein M. Duty to warn. JAMA 1989; 261:1355, 1340.
14. Nissenbaum GD, Newark JD. A physician’s duty to disclose that his patient has AIDS. NJ Med 1989; 86:123-125.
15. Isaacman SH, Closen ML. Notifying contacts of HIV-infected patients; Strategies to use until health agencies assume responsibility. Postgrad Med 1989; 85:42,44,53-55,59.
16. Lo B, Steinbrook RL, Cooke M, et al. Voluntary screening for human immunodeficiency virus (HIV) infection; Weighing the benefits and harms. Ann Intern Med 1989; 110:727-733.
17. Dimas JT, Richland JH. Partner notification and HIV infection: Misconceptions and recommendations. AIDS Publ Pol J 1989; 4:206-211.
18. Jones JL, Wykoff RF, Hollis SL, et al. Partner acceptability of health department notification of HIV exposure, South Carolina. JAMA 1990; 264:1284-1286.
19. Taylor AF, Johnson S, Wyant SR, Dassey DE. Heterosexual and perinatal transmission of human immunodeficiency virus in a low prevalence community. West J Med 1988; 148:171-175.
20. Gostin L, Curran WJ. The limits of compulsion in controlling AIDS. Hastings Cent Rep 1986; December 24-29.
21. Ohi G, Hasegawa T, Kai I. Notification of HIV carriers. Possible effect on uptake of AIDS testing. Lancet 1988; 2:947-949.
22. Osborn JE. AIDS: Politics and science. N Engl J Med 1988; 318:444-447.
23. Archer VE. Psychological defenses and control of AIDS. Am J Publ Health 1989; 79:876-878.
24. Perry S. Warning third parties at risk of AIDS: APA’s policy is a barrier to treatment. Hosp Community Psychiatry 1989; 40:158-161.
25. Andrus JK, Fleming DW, Harger DR, et al. Partner notification: Can it control epidemic syphilis? Ann Intern Med 1990; 112:539-543.
26. Rutherford GW, Woo JM. Contact tracing and the control of human immunodeficiency virus infection. JAMA 1988; 259:3609-3610.
27. Weber JN, McCreanem A, Berrie E, et al. Factors affecting sero-positivity to human T-cell lymphotropic retrovirus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDS. Genitourin Med 1986; 62:177-180.
28. Clumeck N, Taelman H, Hermans P, et al. A cluster of HIV infection among heterosexual people without apparent risk factors. N Engl J Med 1989; 321:1460-1462.
29. Toomey KE, Cates W. Partner notification for the prevention of HIV infection. AIDS 1989; 3 (suppl 1):S57-S62.
30. Daniell FD, Skelly RR, Friedman S, et al. HIV preventive medicine services and public health interventions: The Bethesda experience. Milit Med 1990; 155:27-30.
31. Ramstedt K, Hallhage G, Lundin BI, et al. Contact tracing for human immunodeficiency virus (HIV) infection. Sex Transm Dis 1990; 17:37-41.
32. Harris C, Small CB, Klein RS, et al. Immunodeficiency in female sexual partners of men with acquired immunodeficiency syndrome. N Engl J Med 1983; 308:1181-1184.
33. Redfield RR, Markham PD, Salahuddin SZ, et al. Frequent transmission of HTLV-III among spouses of patients with AIDS-re-lated complex and AIDS. JAMA 1985; 253:1571-1573.
34. Kreiss JK, Kitchen LW, Prinze HE, et al. Antibody to human T-cell lymphotropic retrovirus type III in wives of hemophiliacs: Evidence for heterosexual transmission. Ann Intern Med 1985; 102:623-626.
35. Allain JP. Prevalence of HTLV-III/LAV antibodies in patients with hemophilia and in theirsexual partners in France. N Engl J Med 1986; 315:517-518.
36. Burger H, Weiser B, Robinson WS, et al. Transmission of lymphadenopathy associated virus/human T-cell lymphotropic retrovirus type III in sexual partners-seropositivity does not predict infectivity in all cases. Am J Med 1986; 81:5-10.
37. Padian N, Marquis L, Francis DP, et al. Male-to-female transmission of human immunodeficiency virus. JAMA 1987; 258:788-790.
38. Laurian Y, Peynet J, Verroust F. HIV infection in sexual partners of HIV-seropositive patients with hemophilia. N Engl J Med 1989; 320:183.
39. Winkenwerder W, Kessler AR, Stolec RM. Federal spending for illness caused by the human immunodeficiency virus. N Engl J Med 1989; 320:1598-1624.
40. Volberding PA, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection: A controlled trial in persons with fewer than 500 CD-positive cells per cubic millimeter. N Engl J Med 1990; 322:941-949.
41. Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMWR 1989; 38:S-5, 1-9.
42. Francis DP, Chin J. The prevention of acquired immunodeficiency syndrome in the United States. JAMA 1987; 257:1357-1366.